Endocrinology and Metabolism

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus

Hyun Min Kim, Jung Soo Lim, Byung-Wan Lee, Eun-Seok Kang, Hyun Chul Lee, Bong-Soo Cha

Endocrinol Metab. 2015;30(1):84-91. Published online March 27, 2015
DOI: https://doi.org/10.3803/EnM.2015.30.1.84

Optimal Candidates for the Switch from Glimepiride to Sitagliptin to Reduce Hypoglycemia in Patients with Type 2 Diabetes Mellitus

Hyun Min Kim, Jung Soo Lim, Byung-Wan Lee, Eun-Seok Kang, Hyun Chul Lee, Bong-Soo Cha

Endocrinology and Metabolism. 2015;30(1):84

Link1 Link2 Link3

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin

K. Hermansen, M. Kipnes, E. Luo, D. Fanurik, H. Khatami, P. Stein,

Diabetes, Obesity and Metabolism. 2007;9(5):733-745

Link1 Link2

Efficacy and safety of sitagliptin in elderly patients with type 2 diabetes mellitus: A focus on hypoglycemia

Masahiro Fukuda, Kunihiro Doi, Masahiro Sugawara, Koichi Mochizuki

Journal of Diabetes Investigation. 2018;10(2):383-391

Link1 Link2

Ten-year Follow-up of Sitagliptin Treatment in Type 2 Diabetes Mellitus Patients

Sachiko Hattori

. 2021;

Link1 Link2

Efficacy and safety of glimepiride as initial treatment in Russian patients with type 2 diabetes mellitus

Alexander Sergeevich Ametov, Fatima Totrazovna Abaeva

Diabetes mellitus. 2013;16(4):95-100

Link1 Link2 Link3

Abstract #302: Achievement of Glycemic Goals Without Hypoglycemia with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes Mellitus

Michael Davies, Katherine Merton, Ujjwala Vijapurkar, James Simples, Amy Carroll, Dainius Balis, Frank Vercruysse

Endocrine Practice. 2016;22:86-87

Link1 Link2

Comparison of the efficacy of sitagliptin and glimepiride dose-up in Japanese patients with type 2 diabetes poorly controlled by sitagliptin and glimepiride in combination

Seiya Shimoda, Shinsuke Iwashita, Taiji Sekigami, Noboru Furukawa, Yasuto Matsuo, Shinji Ichimori, Rieko Goto, Takako Maeda, Eiichiro Watanabe, Tatsuya Kondo, Takeshi Matsumura, Hiroyuki Motoshima, Kenro Nishida, Eiichi Araki

Journal of Diabetes Investigation. 2013;5(3):320-326

Link1 Link2 Link3

Hypoglycemia in type 2 diabetes mellitus patients — cerebral, cognitive, psychosocial and clinical aspects

K. V. Antonova, O. V. Lagoda, M. M. Tanashyan

Diabetes mellitus. 2022;25(3):288-298

Link1

Glimepiride Strongly Enhances the Glucose-Lowering Effect in Triple Oral Antidiabetes Therapy with Sitagliptin and Metformin for Japanese Patients with Type 2 Diabetes Mellitus

Keiko Arai, Hajime Maeda, Sin-ichiro Sirabe, Ritsuko Yamamoto, Mikio Yamauchi, Tetsuyuki Hirao, Setsuko Hirao, Koichi Hirao

Diabetes Technology & Therapeutics. 2013;15(4):335-341

Link1 Link2

Efficacy and safety of sitagliptin as compared with glimepiride in Japanese patients with type 2 diabetes mellitus aged ≥ 60 years (START-J trial)

Yasuo Terauchi, Yuichiro Yamada, Hitoshi Ishida, Mitsuru Ohsugi, Masafumi Kitaoka, Jo Satoh, Daisuke Yabe, Nobuyuki Shihara, Yutaka Seino

Diabetes, Obesity and Metabolism. 2017;19(8):1188-1192

Link1 Link2